Federal Register / Vol. 65, No. 236 / Thursday, December 7, 2000 / Notices 76653

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel ZDK1 GRB–7 J2.

Date: December 21, 2000.

Time: 3:00 pm to 4:30 pm.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

NIDDK/DEA/Review Branch, 2 Democracy

Boulevard, 6707 Democracy Boulevard, MSC

5452, Room #659, Bethesda, MD 20892,

(Telephone Conference Call).

Contact Person: Lakshmanan Sankaran,

PhD, Scientific Review Administrator,

Review Branch, DEA, NIDDK, Room 659,

6707 Democracy Boulevard, National

Institutes of Health, Bethesda, MD 20892–

6600, (301) 594–7799.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: November 28, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–31205 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Close Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: December 6, 2000.

Time: 11 am to 12 pm.

Agenda: To review and evaluate grant

applications.

Place: 45 Natcher Bldg, Rm 5As.25u,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Richard J. Bartlett, PhD,

Scientific Review Administrator, National

Institute of Arthritis and Musculoskeletal and

Skin Diseases, Natcher Bldg./Bldg. 45, Room

5As37B, (301) 594–4952.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the require and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institute of Health, HHS)

Dated: December 1, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–31198 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institutes of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel ZDK1 GRB–5(J2).

Date: January 11–12, 2001.

Time: 7:30 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Francisco O. Calvo, PhD.,

Deputy Chief, Review Branch, DEA NIDDK,

Room 655, 6707 Democracy Boulevard,

National Institutes of Health, Bethesda, MD

20892–6600, (301) 594–8897

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS).

Dated: November 28, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–31203 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Deafness and Other Communications

Disorders Special Emphasis Panel.

Date: January 9, 2001.

Time: 2:00 pm to 4:30 pm.

Agenda: To review and evaluate contract

proposals.

Place: 6120 Executive Blvd., Suite 400C,

Rockville, MD 20852, (Telephone Conference

Call).

Contact Person: Craig A. Jordan, Phd,

Chief, Scientific Review Branch, NIH/

NIDCD/DER, Executive Plaza South, Room

400C, Bethesda, MD 20892–7180, 301–496–

8683.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.173, Biological Research

Related to Deafness and Communicative

Disorders, National Institutes of Health, HHS)

Dated: November 28, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–31204 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M